Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV
Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it.
Explore Our Podcasts: hippoed.com/podcasts
